Clinical Trials - Gala Treatment for Chronic Bronchitis in Canada - Chronic Bronchitis
The Gala Airway Treatment system is a device-based, energy delivery system that delivers high frequency short duration energy to the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.
Treatment will be delivered by a respiratory physician (interventional pulmonologist) in a tertiary teaching hospital.
| Study Type : | Interventional  (Clinical Trial) |
| Estimated Enrollment : | 12 participants |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | Treatment with Gala Airway Treatment System |
| Masking: | None (Open Label) |
| Primary Purpose: | Device Feasibility |
| Official Title: | A Feasibility Study: A Safety Evaluation of the Gala Airway Treatment System on Patients With Chronic Bronchitis in Canada |
| Actual Study Start Date | Â January 20, 2017 |
| Estimated Primary Completion Date : | Â June 30, 2018 |
| Estimated Study Completion Dateï¼ | Â June 30, 2019 |
Contacts
| Contact: Jonathan Waldstreicher, MD | jon@galatherapeutics.com |
| Contact: Deborah Sheffield, MS | deb@galatherapeutics.com |
Location
| Austria | |
| Otto Wagner Spital | Recruiting |
| Wien, Austria, A-1140 | |
| Contact: Arschang Valipour, MD   0043 664 4385355   blvr.koordinator@gmail.com   | |
| Principal Investigator: Arschang Valiour, MD | |
| Chile | |
| Clinica Alemana | Recruiting |
| Santiago, Chile | |
| Contact: Carolina Bascuñan   569 934 65819   cbascunan@alemana.cl   | |
| Principal Investigator: Sebastian Fernandez-Bussy, MD | |
| ClinicalTrials.gov Identifier: | NCT03107494 |
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.